Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Novartis describes search for potent and selective CDK1/CDK2 inhibitors

Sep. 2, 1998

AEterna isolates molecule exhibiting anti-MMP activity

Sep. 2, 1998

Orphan drug designation granted for thalidomide in KS

Sep. 1, 1998

News from the ACS: Btk inhibitor LFM-A13 promotes apoptosis in leukemia cells

Sep. 1, 1998

Profile of TI-138067, a novel tubulin inhibitor in phase I testing

Sep. 1, 1998

ProScript team describes novel Ras endoprotease inhibitor at ACS meeting

Sep. 1, 1998

New anticancer agents discovered at American Cyanamid

Sep. 1, 1998

Prolifix and BioFocus to cooperate on cancer drug development

Sep. 1, 1998

Boehringer Mannheim reports new discovery in cancer research

Sep. 1, 1998

Northwest Biotherapeutics patents dendritic cell-based immunotherapy for prostate cancer

Sep. 1, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 13, 2026.
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...